SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:57f7dc3b-a1e6-4a3c-abe1-e359e3e367c2"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:57f7dc3b-a1e6-4a3c-abe1-e359e3e367c2" > Factor V and thromb...

Factor V and thrombotic disease: description of a janus-faced protein.

Nicolaes, Gerry A F (författare)
Dahlbäck, Björn (författare)
Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Chemistry, Malmö,Lund University Research Groups
 (creator_code:org_t)
2002
2002
Engelska.
Ingår i: Arteriosclerosis, Thrombosis and Vascular Biology. - 1524-4636. ; 22:4, s. 530-538
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • The generation of thrombin by the prothrombinase complex constitutes an essential step in hemostasis, with thrombin being crucial for the amplification of blood coagulation, fibrin formation, and platelet activation. In the prothrombinase complex, the activated form of coagulation factor V (FVa) is an essential cofactor to the enzyme-activated factor X (FXa), FXa being virtually ineffective in the absence of its cofactor. Besides its procoagulant potential, intact factor V (FV) has an anticoagulant cofactor capacity functioning in synergy with protein S and activated protein C (APC) in APC-catalyzed inactivation of the activated form of factor VIII. The expression of anticoagulant cofactor function of FV is dependent on APC-mediated proteolysis of intact FV. Thus, FV has the potential to function in procoagulant and anticoagulant pathways, with its functional properties being modulated by proteolysis exerted by procoagulant and anticoagulant enzymes. The procoagulant enzymes factor Xa and thrombin are both able to activate circulating FV to FVa. The activity of FVa is, in turn, regulated by APC together with its cofactor protein S. In fact, the regulation of thrombin formation proceeds primarily through the upregulation and downregulation of FVa cofactor activity, and failure to control FVa activity may result in either bleeding or thrombotic complications. A prime example is APC resistance, which is the most common genetic risk factor for thrombosis. It is caused by a single point mutation in the FV gene (factor V(Leiden)) that not only renders FVa less susceptible to the proteolytic inactivation by APC but also impairs the anticoagulant properties of FV. This review gives a description of the dualistic character of FV and describes the gene-gene and gene-environment interactions that are important for the involvement of FV in the etiology of venous thromboembolism.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Venous Thrombosis : blood
Thrombin : metabolism
Protein S : physiology
Protein C : physiology
Protein C : genetics
Point Mutation
Phenotype
Activated Protein C Resistance : genetics
Blood Coagulation : physiology
Caucasoid Race
Factor V : biosynthesis
Factor V : genetics
Factor V : metabolism
Factor V : physiology
Factor VIII : genetics
Factor VIII : physiology
Factor Va : physiology
Factor Va : genetics
Factor Xa : metabolism
Factor Xa : physiology
Human
Venous Thrombosis : genetics

Publikations- och innehållstyp

for (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Nicolaes, Gerry ...
Dahlbäck, Björn
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Kardiologi
Artiklar i publikationen
Arteriosclerosis ...
Av lärosätet
Lunds universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy